Metoclopramide Hydrochloride Svp Pharma (Metoclopramide Hydrochloride Monohydrate)

Metoclopramide works by blocking dopamine D2 receptors in the chemoreceptor trigger zone of the brain, which reduces the neural signals that trigger nausea. Additionally, it antagonizes serotonin 5‑HT3 receptors and stimulates 5‑HT4 receptors in the gut, promoting coordinated muscular contractions that speed gastric emptying.

The appropriate dose of Metoclopramide is determined by the prescribing clinician based on the specific indication, patient age, weight, renal function, and severity of symptoms. Dosage regimens may differ for acute nausea, chronic gastroparesis, or postoperative use, and should always follow the prescriber’s written order.

Metoclopramide should be used during pregnancy or lactation only when the potential benefit justifies the potential risk to the fetus or infant. Limited data suggest it may be considered for severe nausea when other options are unsuitable, but clinicians should evaluate each case individually and discuss risks with the patient.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Metoclopramide Hydrochloride Svp Pharma. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and required import documentation.

Metoclopramide differs from serotonin‑type antiemetics like ondansetron by primarily targeting dopamine D2 receptors, while also affecting serotonin pathways. It has the added benefit of enhancing gastrointestinal motility, making it useful for gastroparesis. However, it carries a higher risk of extrapyramidal side effects, whereas ondansetron is generally better tolerated but lacks pro‑kinetic activity.

The product should be stored at 2‑8 °C (refrigerated). Keep the vials in their original packaging, protect them from light, and avoid freezing or shaking. If a temporary temperature excursion occurs, consult the product’s stability data before use.

Metoclopramide is supplied as an injectable solution for intramuscular (IM) or intravenous (IV) administration. The route, infusion rate, and concentration are determined by the prescriber based on the clinical situation. Intravenous injection is often given slowly to reduce the risk of cardiovascular side effects.

Serious adverse events include extrapyramidal reactions such as acute dystonia, tardive dyskinesia (potentially irreversible facial or tongue movements), and neuroleptic malignant syndrome, a life‑threatening condition with fever and muscle rigidity. Prompt medical attention is required if any of these symptoms develop.

Metoclopramide is contraindicated in patients with known hypersensitivity to the drug, those with pheochromocytoma, and individuals with a history of seizure disorders or severe depression. Caution is also advised for patients with Parkinson’s disease, gastrointestinal obstruction, or significant renal impairment.